Patients experienced robust declines in systolic and diastolic pressure after receiving intrathecal clonidine.
Even blood pressure not considered hypertensive may reflect latent risk for adverse outcomes.
In a small study, spironolactone decreased blood pressure with no significant rise in potassium.
Adding other seasonings to food could diminish this preference, new findings suggest.
Data show sustained blood pressure reductions two years after the procedure.
Blood pressure increased in hypertensive patients who took calls before measurements were obtained.
Ambulatory blood pressure monitoring is necessary for the proper evaluation of cardiovascular disease risk, researchers conclude.
NEW YORK—The more alcohol a man drinks per day, the greater his risk for developing hypertension, according to a recent study.
NEW YORK—Reduced left ventricular ejection fraction (LVEF) is associated with an increased likelihood of cardiovascular (CV) and all-cause mortality in very elderly patients, data show. This association is independent of traditional CV risk factors, according to investigators.
NEW YORK—Long-term data show that a three-drug combination is safe and effective for treating hypertension in elderly patients, according to a report at the American Society of Hypertension annual meeting.
NEW YORK—A combination of aliskiren and hydrochlorothiazide (HCTZ) is an effective first-line treatment option for older patients with stage 2 hypertension, even those with diabetes or metabolic syndrome, investigators concluded.
NEW YORK—Using a thiazolidinedione (TZD) drug in combination with a statin may decrease systemic inflammation and reduce the incidence of new-onset diabetes among patients with metabolic syndrome, data suggest.
NEW YORK—New findings suggest that electronic health records (EHR) with special features for managing hypertension may be highly beneficial in improving BP control.
Improvements in exercise capacity are associated with decreased mortality among prehypertensive men, data show.
Telmisartan plus amlodipine is superior to losartan plus amlodipine in reducing microalbuminuria in hypertensive patients with type 2 diabetes, Italian researchers reported.